Efficacy of Treatment for Obsessive Compulsive Disorder

This study has been completed.
Sponsor:
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00457028
First received: April 3, 2007
Last updated: June 7, 2011
Last verified: June 2011
  Purpose

The purpose of these questionnaires is to give us an overview of how OCD has affected your life and perhaps also to give us some clues about things that may have set you up to experience OCD.


Condition
Obsessive Compulsive Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Efficacy of Treatment for Obsessive Compulsive Disorder

Resource links provided by NLM:


Further study details as provided by University of British Columbia:

Estimated Enrollment: 250
Study Start Date: May 2003
Study Completion Date: June 2011
Detailed Description:

For us to evaluate the efficacy of our treatment programs, we are interested in your responses before and after treatment. We use two methods to evaluate the efficacy of our treatments: questionnaires and interviews with a member of the Anxiety Disorders Clinic. As part of standard clinic procedure, each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment. If you have received this questionnaire packet, it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic. The purpose of the questionnaire packet is to assess the severity of your obsessive-compulsive disorder; its impact on your functioning, and factors that may contribute to the onset or maintenance of your OCD (e.g., depression, personal standards). We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic.

  Eligibility

Ages Eligible for Study:   19 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Participants in the study will be recruited from individuals receiving treatment at the Anxiety Disorders Clinic of UBC Hospital.

Criteria

Inclusion Criteria:

  • Patients referred to the Anxiety Disorders Clinic who receive a primary diagnosis of Obsessive Compulsive Disorder, and are accepted for treatment at the clinic.

Exclusion Criteria:

  • Individuals who either have not sought treatment for anxiety at the Anxiety Disorders Clinic or patients who did not receive a primary diagnosis of Obsessive Compulsive Disorder.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00457028

Locations
Canada, British Columbia
Anxiety Disorders Clinic, University of British Columbia
Vancouver, British Columbia, Canada, V6T 1Z9
Sponsors and Collaborators
University of British Columbia
Investigators
Principal Investigator: Maureen Whittal, Ph.D University of British Columbia
  More Information

No publications provided

Responsible Party: Dr. Maureen Whittal, University of British Columbia
ClinicalTrials.gov Identifier: NCT00457028     History of Changes
Other Study ID Numbers: H03-80266
Study First Received: April 3, 2007
Last Updated: June 7, 2011
Health Authority: Canada: Health Canada

Keywords provided by University of British Columbia:
Obsessive Compulsive Disorder
Anxiety
Treatment efficacy

Additional relevant MeSH terms:
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Disease
Personality Disorders
Mental Disorders
Anxiety Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 19, 2014